By Carla Mozee, MarketWatch
LONDON (MarketWatch) -- U.K. stocks rose Thursday, in
broad-based gains that included a higher move for AstraZeneca
following regulatory approval of a drug to treat cancer.
The FTSE 100 rose 0.8% to 6,384.51 as all sectors advanced. Most
oil and gas stocks continued to build on Wednesday's advance, when
the sector staged a turnaround late in the session on a rebound in
oil prices. Tullow Oil rose 2.3% and oil-services firm Petrofac
Ltd. put in 2.1%, while Royal Dutch Shell PLC swung to a 0.2%
rise.
U.S. crude-oil futures on Wednesday came off a five-year low
after data showed U.S. crude inventories declined, although the
drop was less than forecast.
AstraZeneca PLC shares tacked on 1% as the European Commission
approved the company's Lynparza capsules for use by patients with
ovarian cancer. The drug may be used in all 28 EU member states, as
well as in Norway, Iceland and Liechtenstein.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires